(Neo-)Adjuvant Ipilimumab Plus Nivolumab (Ipi Plus Nivo) In Palpable Stage 3 Melanoma - Initial Data From The Opacin TrialC. Blank,A. Van Akkooi,E. A. Rozeman, P. Kvistborg,H. V. Van Thienen,B. Stegenga, B. Lamon,J. B. A. G. Haanen, T. SchumacherANNALS OF ONCOLOGY(2016)引用 6|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要